{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:50:16Z","timestamp":1791546616013,"version":"4.3.4"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1208\/s12249-019-1382-3","type":"journal-article","created":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T17:02:39Z","timestamp":1562000559000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Pulmonary and Regional Deposition of Nebulized and Dry Powder Aerosols in Ferrets"],"prefix":"10.1208","volume":"20","author":[{"given":"Philip J.","family":"Kuehl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"Chand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob D.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Hava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wesley H.","family":"DeHaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,1]]},"reference":[{"issue":"1","key":"1382_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3109\/08958378.2011.632787","volume":"24","author":"PJ Kuehl","year":"2012","unstructured":"Kuehl PJ, Anderson T, Candelaria G, Gershman B, Harlin K, Hesterman JY, et al. Regional particle size dependent deposition of inhaled aerosols in rats and mice. Inhal Toxicol. 2012;24(1):27\u201335.","journal-title":"Inhal Toxicol"},{"key":"1382_CR2","doi-asserted-by":"crossref","unstructured":"Garcia, A., Mack P, Williams S, Fromen C, Shen T, Pillai J, Kuehl PJ, Napier M, Desimon JM, Maynor BW. Microfabricated engineered particle systems for respiratory drug delivery and other pharmaceutical applications. J Drug Deliv 2012;Article ID 941243.","DOI":"10.1155\/2012\/941243"},{"issue":"11","key":"1382_CR3","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1080\/08958370802105413","volume":"20","author":"YS Cheng","year":"2008","unstructured":"Cheng YS, Irshad H, Kuehl PJ, Holmes TD, Sherwood R, Hobbs CH. Lung deposition of droplet aerosols in monkeys. Inhal Toxicol. 2008;20(11):1029\u201336.","journal-title":"Inhal Toxicol"},{"key":"1382_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/089583700196536","volume":"12","author":"FJ Miller","year":"2000","unstructured":"Miller FJ. Dosimeter of particles in laboratory animals and humans in relationship to issues surrounding lung overload and human health risk assessment: a critical review. Inhal Toxicol. 2000;12:19\u201357.","journal-title":"Inhal Toxicol"},{"issue":"13","key":"1382_CR5","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1080\/08958370802207318","volume":"20","author":"DJ Alexander","year":"2008","unstructured":"Alexander DJ, Collins CJ, Coombs DW, Gilkison IS, Hardy CJ, Healey G, Karantabias G, Johnson N, Karlsson A, Kilgour JD, .McDonald P. 'Association of Inhalation Toxicologists (AIT) working party recommendation for standard delivered dose calculation and expression in non-clinical aerosol inhalation toxicology studies with pharmaceuticals', Inhal Toxicol 2008;20(13):1179\u20131189.","journal-title":"Inhal Toxicol"},{"key":"1382_CR6","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1242\/dmm.007823","volume":"4","author":"JA Belser","year":"2011","unstructured":"Belser JA, Jacqueline MK, Tumpey TM. The ferret as a model organism to study influenza A virus infection. Dis Model Mech. 2011;4:575\u20139.","journal-title":"Dis Model Mech"},{"issue":"9","key":"1382_CR7","doi-asserted-by":"publisher","first-page":"e24448","DOI":"10.1371\/journal.pone.0024448","volume":"6","author":"H MacInnes","year":"2011","unstructured":"MacInnes H, Zhou Y, Gouveia K, Cromwell J, Lowery L, Layton RC, et al. Transmission of aerosolized seasonal H1N1 influenza A to ferrets. PLoS One. 2011;6(9):e24448.","journal-title":"PLoS One"},{"key":"1382_CR8","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/1743-422X-7-231","volume":"7","author":"JA Lednicky","year":"2010","unstructured":"Lednicky JA, Hamilton SB, Tuttle RS, Sosna WA, Daniels DE, Swayne DE. Ferrets develop fatal influenza after inhaling small particle aerosols of highly pathogenic avian influenza virus A\/Vietnam\/1203\/2004 (H5N1). Virol J. 2010;7:231.","journal-title":"Virol J"},{"issue":"1","key":"1382_CR9","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1089\/humc.2014.154","volume":"26","author":"Y Ziying","year":"2015","unstructured":"Ziying Y, Steward ZA, Sinn PL, Olsen JC, Hu J, McCray PB, et al. Ferret and pig models of cystic fibrosis: prospects and promise for gene therapy. Hum Gene Ther Clin Dev. 2015;26(1):38\u201349.","journal-title":"Hum Gene Ther Clin Dev"},{"key":"1382_CR10","first-page":"80","volume":"7","author":"YO Ding","year":"2016","unstructured":"Ding YO, Hurt AC. Using the ferret as an animal model for investigating influenza antiviral effectiveness. Front Microbiol. 2016;7:80.","journal-title":"Front Microbiol"},{"key":"1382_CR11","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.antiviral.2015.05.007","volume":"120","author":"J Panozzo","year":"2015","unstructured":"Panozzo J, Oh DY, Margo K, Morton DA, Piedrafita D, Mosse J, et al. Evaluation of a dry powder delivery system for laninamivir in a ferret model of influenza infection. Antivir Res. 2015;120:66\u201371.","journal-title":"Antivir Res"},{"issue":"7","key":"1382_CR12","doi-asserted-by":"publisher","first-page":"512","DOI":"10.7326\/0003-4819-156-7-201204030-00411","volume":"157","author":"J Hsu","year":"2012","unstructured":"Hsu J, Santesso N, Mustafa R, Brozek J, Chen YL, Hopkins JP, et al. Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies. Ann Intern Med. 2012;157(7):512\u201324.","journal-title":"Ann Intern Med"},{"issue":"Suppl 1","key":"1382_CR13","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1089\/jamp.2012.1Su2","volume":"25","author":"TE Corcoran","year":"2012","unstructured":"Corcoran TE, Devadason SG, Kuehl PJ. Introduction: aerosol delivery of orally inhaled agents. J Aerosol Med Pulm Drug Deliv. 2012;25(Suppl 1):S3\u20135.","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"Suppl 1","key":"1382_CR14","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1089\/jamp.2012.1Su3","volume":"25","author":"SG Devadason","year":"2012","unstructured":"Devadason SG, Chan HK, Haussermann S, Kietzig C, Kuehl PJ, Newman S, et al. Standardization of techniques for validation of radiolabeling of drug formulations for aerosol deposition assessment of orally inhaled products. J Aerosol Med Pulm Drug Deliv. 2012;25(Suppl 1):S6\u20139.","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"4","key":"1382_CR15","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1177\/1091581815624080","volume":"35","author":"JS Tepper","year":"2016","unstructured":"Tepper JS, Kuehl PJ, Cracknell S, Nikula KJ, Pei L, Blanchard JD. Symposium summary: \u201cbreathe in, breath out, its easy: what you need to know about developing inhaled drugs\u201d. Int J Toxicol. 2016;35(4):376\u201392.","journal-title":"Int J Toxicol"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-019-1382-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12249-019-1382-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-019-1382-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T23:08:29Z","timestamp":1593472109000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12249-019-1382-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,1]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["1382"],"URL":"https:\/\/doi.org\/10.1208\/s12249-019-1382-3","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,1]]},"assertion":[{"value":"18 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"David L. Hava and Wesley H. DeHaan were employees of Pulmatrix and held an interest in commercializing products based on aspects of this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"242"}}